Mary Lynn Trawick

1.3k citations

50 papers · 1.1k indexed · h-index 21

Toxicology top 2%
- Bioactive Compounds and Antitumor Agents 6
Organic Chemistry top 2%
- Synthesis and biological activity 20
- Click Chemistry and Applications 11
Cancer Research top 10%
- Protease and Inhibitor Mechanisms 8
- Cancer, Hypoxia, and Metabolism 5
Pharmacology top 10%
Molecular Biology
- Bone Metabolism and Diseases 6
- Angiogenesis and VEGF in Cancer 4
Biomedical Engineering
- Nanoplatforms for cancer theranostics 10

Co-authors: Kevin G. Pinney Tracy E. Strecker David J. Chaplin Ralph P. Mason Ernest Hamel Shen-En Chen Rajendra P. Tanpure Dawen Zhao
Cited by: Toxicology Organic Chemistry Cancer Research
Partner nations: United States Denmark Sweden

In The Last Decade

Mary Lynn Trawick

49 papers receiving 1.1k citations

Peers

Countries citing papers authored by Mary Lynn Trawick

Since Specialization

Citations

This map shows the geographic impact of Mary Lynn Trawick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Lynn Trawick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Lynn Trawick more than expected).

Fields of papers citing papers by Mary Lynn Trawick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Lynn Trawick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Lynn Trawick. The network helps show where Mary Lynn Trawick may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mary Lynn Trawick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mary Lynn Trawick Line = papers co-authored together Mary Lynn Trawick links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice Hashini Wanniarachchi,Regan Schuetze,Yuling Deng,Khagendra B. Hamal,Cyprian I. Pavlich,Pouguiniseli E. Tankoano,C. Tamminga,Hans J. Hammers,Payal Kapur,Lorena M. A. Bueno,Ricardo Rayas,Tianyuan Wang,Li Liu,Mary Lynn Trawick,Kevin G. Pinney,Ralph P. Mason	2025	2
2	Targeting tumor-associated hypoxia with bioreductively activatable prodrug conjugates derived from dihydronaphthalene, benzosuberene, and indole-based inhibitors of tubulin polymerization Zhe Shi,Rajsekhar Guddneppanavar,Blake A. Winn,Matthew T. MacDonough,Clinton S. George,Yifan Wang,Mariusz Zimmer,Jeni Gerberich,Alex Winters,Elisa Lin,Casey J. Maguire,Jacob W. Ford,Ernest Hamel,Ralph P. Mason,Mary Lynn Trawick,Kevin G. Pinney	2025	0
3	Design, Synthesis and Biological Evaluation of 2-Phenyl Indole Analogues of OXi8006 as Colchicine Site Inhibitors of Tubulin Polymerization and Vascular Disrupting Agents Rebecca Vairin,C. Tamminga,Zhe Shi,Christian Borchardt,Jayaram Jambulapati,Ruoli Bai,Hashini Wanniarachchi,Lorena M. A. Bueno,Ernest Hamel,Ralph P. Mason,Mary Lynn Trawick,Kevin G. Pinney	2024	4
4	Drug-linker constructs bearing unique dual-mechanism tubulin binding payloads tethered through cleavable and non-cleavable linkers Jacob W. Ford,Jennifer M. VanNatta,Deboprosad Mondal,Chen-Ming Lin,Yuling Deng,Ruoli Bai,Ernest Hamel,Mary Lynn Trawick,Kevin G. Pinney	2024	1
5	Acute vasculature disruption in orthotopic kidney tumors based on vascular disrupting agent (OXi8007) examined by multispectral optoacoustic tomography (MSOT) Hashini Wanniarachchi,Lorena M. A. Bueno,Ricardo Rayas,Khagendra B. Hamal,Cyprian I. Pavlich,Mary Lynn Trawick,Kevin G. Pinney,Li Liu,Ralph P. Mason	2024	1
6	Structure Guided Design, Synthesis, and Biological Evaluation of Oxetane-Containing Indole Analogues Wen Ren,Rebecca Vairin,J. WARD,Ricardo Francis,Jenny M. VanNatta,Ruoli Bai,Pouguiniseli E. Tankoano,Yuling Deng,Ernest Hamel,Mary Lynn Trawick,Kevin G. Pinney	2023	2
7	Synthesis and biological evaluation of structurally diverse 6-aryl-3-aroyl-indole analogues as inhibitors of tubulin polymerization Wen Ren,Yuling Deng,J. WARD,Rebecca Vairin,Ruoli Bai,Hashini Wanniarachchi,Khagendra B. Hamal,Pouguiniseli E. Tankoano,C. Tamminga,Lorena M.A. Bueno,Ernest Hamel,Ralph P. Mason,Mary Lynn Trawick,Kevin G. Pinney	2023	14
8	Synthesis and biological evaluation of structurally diverse α-conformationally restricted chalcones and related analogues Casey J. Maguire,Graham J. Carlson,Jacob W. Ford,Tracy E. Strecker,Ernest Hamel,Mary Lynn Trawick,Kevin G. Pinney	2019	11
9	Bioreductively activatable prodrug conjugates of phenstatin designed to target tumor hypoxia Blake A. Winn,Zhe Shi,Graham J. Carlson,Yifan Wang,Benson L. Nguyen,Evan M. Kelly,Rebecca Ross,Ernest Hamel,David J. Chaplin,Mary Lynn Trawick,Kevin G. Pinney	2016	16
10	Abstract 4194: Assessment of novel benzosuberene-based vascular disrupting agents (VDA) on diverse tumor lines Li Liu,Mary Lynn Trawick,Kevin G. Pinney,Ralph P. Mason	2016	1
11	Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents Laxman Devkota,Chen-Ming Lin,Tracy E. Strecker,Yifan Wang,Justin K. Tidmore,Zhi Chen,Rajsekhar Guddneppanavar,Christopher J. Jelinek,Ramona Lopez,Li Liu,Ernest Hamel,Ralph P. Mason,David J. Chaplin,Mary Lynn Trawick,Kevin G. Pinney	2016	42
12	Small-molecule inhibitors of cathepsin L incorporating functionalized ring-fused molecular frameworks Jiang-Li Song,Lindsay M. Jones,Gustavo E. Chavarria,Amanda K. Charlton-Sevcik,Adam Jantz,Audra Johansen,Liela Bayeh,Victoria Soeung,Lindsey K. Snyder,Shawn D. Lade,David J. Chaplin,Mary Lynn Trawick,Kevin G. Pinney	2012	20
13	An amino-benzosuberene analogue that inhibits tubulin assembly and demonstrates remarkable cytotoxicity Rajendra P. Tanpure,Clinton S. George,Madhavi Sriram,Tracy E. Strecker,Justin K. Tidmore,Ernest Hamel,Amanda K. Charlton-Sevcik,David J. Chaplin,Mary Lynn Trawick,Kevin G. Pinney	2012	31
14	A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment Ralph P. Mason,Dawen Zhao,Li Liu,Mary Lynn Trawick,Kevin G. Pinney	2011	89
15	Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors G.D. Kishore Kumar,Gustavo E. Chavarria,Amanda K. Charlton-Sevcik,Wara M. Arispe,Matthew T. MacDonough,Tracy E. Strecker,Shen-En Chen,Bronwyn G. Siim,David J. Chaplin,Mary Lynn Trawick,Kevin G. Pinney	2010	37
16	Functionalized benzophenone, thiophene, pyridine, and fluorene thiosemicarbazone derivatives as inhibitors of cathepsin L G.D. Kishore Kumar,Gustavo E. Chavarria,Amanda K. Charlton-Sevcik,Grace Kim Yoo,Jiang-Li Song,Tracy E. Strecker,Bronwyn G. Siim,David J. Chaplin,Mary Lynn Trawick,Kevin G. Pinney	2010	34
17	Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4 John J. Hall,Madhavi Sriram,Tracy E. Strecker,Justin K. Tidmore,Christopher J. Jelinek,G.D. Kishore Kumar,Mallinath B. Hadimani,George R. Pettit,David J. Chaplin,Mary Lynn Trawick,Kevin G. Pinney	2008	19
18	Design, synthesis, and biochemical evaluation of novel cruzain inhibitors with potential application in the treatment of Chagas’ disease Rogelio Siles,Shen-En Chen,Ming Zhou,Kevin G. Pinney,Mary Lynn Trawick	2006	64
19	Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents Keith A. Monk,Rogelio Siles,Mallinath B. Hadimani,Benon E. Mugabe,J. Freeland Ackley,Scott W. Studerus,Klaus Edvardsen,Mary Lynn Trawick,C. Michael Garner,Monte R. Rhodes,George R. Pettit,Kevin G. Pinney	2006	68
20	Spectrophotometric Assays for l-Lysine α-Oxidase and γ-Glutamylamine Cyclotransferase Jedidah Danson,Mary Lynn Trawick,Arthur J.L. Cooper	2002	15

About Mary Lynn Trawick

Mary Lynn Trawick is a scholar working on Toxicology, Organic Chemistry and Cancer Research, having authored 50 papers that have together received 1.1k indexed citations. Recurring topics across this work include Synthesis and biological activity (20 papers), Click Chemistry and Applications (11 papers), Nanoplatforms for cancer theranostics (10 papers), Protease and Inhibitor Mechanisms (8 papers), Bioactive Compounds and Antitumor Agents (6 papers), Bone Metabolism and Diseases (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Angiogenesis and VEGF in Cancer (4 papers). The work is most often cited by research in Toxicology (93 citations), Organic Chemistry (722 citations) and Cancer Research (193 citations). Mary Lynn Trawick has collaborated with scholars based in United States, Denmark and Sweden. Frequent co-authors include Kevin G. Pinney, Tracy E. Strecker, David J. Chaplin, Ralph P. Mason, Ernest Hamel, Shen-En Chen, Rajendra P. Tanpure, Dawen Zhao, Li Liu and Mallinath B. Hadimani.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact